Literature DB >> 6240017

Characteristics and functional capacities of human cord blood granulocytes and monocytes.

L Maródi, P C Leijh, R van Furth.   

Abstract

Cord blood phagocytic cells were characterized with respect to cytochemical activities, Fc gamma and C3b receptors, and capacity to phagocytose and kill various species of bacteria. The percentages of peroxidase-positive granulocytes and monocytes from neonates and adults were comparable; the percentage of esterase-positive cord-blood monocytes was about two-thirds of that of adults' blood monocytes. The numbers of cord blood and adults' monocytes with Fc gamma and C3b receptors were similar. Phagocytic and intracellular killing capacities of cord blood granulocytes and monocytes were investigated for Staphylococcus aureus, Escherichia coli, Streptococcus pyogenes, and group B Streptococcus type III. The rates of phagocytosis and intracellular killing by granulocytes from newborns proved to be comparable to the corresponding values for granulocytes from adults. Cord blood monocytes phagocytosed E. coli, S. aureus, and S. pyogenes at a normal rate, and killed ingested E. coli and S. pyogenes intracellularly at the same rate as adults' monocytes did. However, S. aureus was killed at a much lower rate by cord blood monocytes than by monocytes from adults. Phagocytic activity for group B Streptococcus was impaired and killing of these bacteria by cord blood monocytes was virtually nil. The latter finding might partially explain the frequent streptococcal infections in newborns.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6240017     DOI: 10.1203/00006450-198411000-00014

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  20 in total

Review 1.  Interaction of neonatal phagocytes with group B streptococcus: recognition and response.

Authors:  Philipp Henneke; Reinhard Berner
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

Review 2.  Neonatal innate immunity to infectious agents.

Authors:  László Maródi
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

3.  Amniotic fluid neutrophils can phagocytize bacteria: A mechanism for microbial killing in the amniotic cavity.

Authors:  Nardhy Gomez-Lopez; Roberto Romero; Valeria Garcia-Flores; Yi Xu; Yaozhu Leng; Ali Alhousseini; Sonia S Hassan; Bogdan Panaitescu
Journal:  Am J Reprod Immunol       Date:  2017-07-13       Impact factor: 3.886

4.  Specialized Proresolving Mediators Rescue Infant Mice from Lethal Citrobacter rodentium Infection and Promote Immunity against Reinfection.

Authors:  Luis Alonso Diaz; Norman H Altman; Wasif N Khan; Charles N Serhan; Becky Adkins
Journal:  Infect Immun       Date:  2017-09-20       Impact factor: 3.441

5.  Comparison of cytotoxic properties of neonatal and adult neutrophils and monocytes and enhancement by cytokines.

Authors:  E R Stiehm; R L Roberts; B J Ank; S Plaeger-Marshall; N Salman; L Shen; M W Fanger
Journal:  Clin Diagn Lab Immunol       Date:  1994-05

6.  Phagocytic activities in neonatal monocytes.

Authors:  C P Speer; M Wieland; R Ulbrich; M Gahr
Journal:  Eur J Pediatr       Date:  1986-10       Impact factor: 3.183

7.  Opsonin-independent phagocytosis of group B streptococci: role of complement receptor type three.

Authors:  J M Antal; J V Cunningham; K J Goodrum
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

8.  Fc gamma RI and Fc gamma RIII on polymorphonuclear leucocytes in cord blood.

Authors:  N Takahashi; H Nishida; T Kuratsuji
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-01       Impact factor: 5.747

Review 9.  Molecular mechanisms of mucocutaneous immunity against Candida and Staphylococcus species.

Authors:  László Maródi; Sophie Cypowyj; Beáta Tóth; Liudmyla Chernyshova; Anne Puel; Jean-Laurent Casanova
Journal:  J Allergy Clin Immunol       Date:  2012-10-03       Impact factor: 10.793

10.  Functions of granulocytes and monocytes in primary biliary and alcoholic cirrhosis.

Authors:  A Blussé van Oud; A R Janssens; P C Leijh; R van Furth
Journal:  Clin Exp Immunol       Date:  1985-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.